Overview

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the proportion of patients with viral load of HIV-1 < 50 copies after 48 weeks of follow-up after randomization to change or not to nevirapine.

Phase:

Phase 4

Details

Lead Sponsor:

Hospital de Calella

Treatments:

Nevirapine